Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1938-1947

  Schiffer, Lena ^d   Bethunaickan, Ramalingam ^a   Ramanujam, Meera ^a   Huang, Weiqing ^a   Schiffer, Mario ^d   Tao, Haiou ^a   Madaio, Michael M ^b   Bottinger, Erwin P ^c   Davidson, Anne ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; AUTACOID; CD40 LIGAND MONOCLONAL ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CYCLOPHOSPHAMIDE; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ANTIBODY CONJUGATE; BIOLOGICAL MARKER; CD40 LIGAND; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL INFILTRATION; CELL INVASION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; GLOMERULONEPHRITIS; GLOMERULUS; IMMUNE COMPLEX DEPOSITION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; KIDNEY PELVIS; KIDNEY PERFUSION; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; REMISSION; SINGLE DRUG DOSE; ANIMAL; DISEASE COURSE; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; KIDNEY; LYMPHOCYTE; MACROPHAGE ACTIVATION; PATHOLOGY;

ANIMALS; BIOLOGICAL MARKERS; CD40 LIGAND; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KIDNEY; LUPUS NEPHRITIS; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED NZB; PROTEINURIA; REMISSION INDUCTION;

EID: 40749132629     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1938     Document Type: Article

References (43)

1. Davidson, A., and C. Aranow. 2006. Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr. Opin. Rheumatol. 18: 468-475.
2. 1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171: 489-497.
3. Ramanujam, M., X. Wang, W. Huang, Z. Liu, L. Schiffer, H. Tao, D. Frank, J. Rice, B. Diamond, K. O. Yu, et al. 2006. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J. Clin. Invest. 116: 724-734.
4. Chan, O., M. P. Madaio, and M. J. Shlomchik. 1997. The roles of B cells in MRL/lpr murine lupus. Ann. NY Acad. Sci. 815: 75-87.
5. Schmidt-Ott, K. M., K. Mori, J. Y. Li, A. Kalandadze, D. J. Cohen, P. Devarajan, and J. Barasch. 2007. Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 18: 407-413.
6. Mori, K., and K. Nakao. 2007. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 71: 967-970.
7. Brunner, H. I., M. Mueller, C. Rutherford, M. H. Passo, D. Witte, A. Grom, J. Mishra, and P. Devarajan. 2006. Urinary neutrophil gelatinase- associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 54: 2577-2584.
8. Ramanujam, M., X. Wang, W. Huang, L. Schiffer, C. Grimaldi, A. Akkerman, B. Diamond, M. P. Madaio, and A. Davidson. 2004. Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J. Immunol. 173: 3524-3534.
9. Muehrcke, R. C., R. M. Kark, C. L. Pirani, and V. E. Pollak. 1957. Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine 36: 1-145.
10. Kuroiwa, T., and E. G. Lee. 1998. Cellular interactions in the pathogenesis of lupus nephritis: the role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 7: 597-603.
11. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148: 1198-1215.
12. Fitzhugh, D. J., S. Naik, S. W. Caughman, and S. T. Hwang. 2000. Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J. Immunol. 165: 6677-6681.
13. Kohler, R. E., A. C. Caon, D. O. Willenborg, I. Clark-Lewis, and S. R. McColl. 2003. A role for macrophage inflammatory protein-3 α/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 170: 6298-6306.
14. Kunkel, E. J., and E. C. Butcher. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3: 822-829.
15. Manzo, A., S. Paoletti, M. Carulli, M. C. Blades, F. Barone, G. Yanni, O. Fitzgerald, B. Bresnihan, R. Caporali, C. Montecucco, et al. 2005. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur. J. Immunol. 35: 1347-1359.
16. Steinmetz, O. M., U. Panzer, U. Kneissler, S. Harendza, M. Lipp, U. Helmchen, and R. A. Stahl. 2005. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int. 67: 1616-1621.
17. Bagaeva, L. V., P. Rao, J. M. Powers, and B. M. Segal. 2006. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 176: 7676-7685.
18. +- dendritic cells in murine lupus and preferential chemotaxis of B1 cells toward BLC. J. Exp. Med. 193: 1393-1402.
19. Schneider, K., K. G. Potter, and C. F. Ware. 2004. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol. Rev. 202: 49-66.
20. 1 mice which can be matured by TNF-α into BLC/CXCL13-producing DC. Eur. J. Immunol. 32: 1881-1887.
21. +- regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
22. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Backstrom, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
23. Fife, B. T., I. Guleria, M. Gubbels Bupp, T. N. Eagar, Q. Tang, H. Bour-Jordan, H. Yagita, M. Azuma, M. H. Sayegh, and J. A. Bluestone. 2006. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203: 2737-2747.
24. Keir, M. E., L. M. Francisco, and A. H. Sharpe. 2007. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19: 309-314.
25. Vielhauer, V., H. J. Anders, and D. Schlondorff. 2007. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis. Semin. Nephrol. 27: 81-97.
26. Peterson, K. S., J. F. Huang, J. Zhu, V. D'Agati, X. Liu, N. Miller, M. G. Erlander, M. R. Jackson, and R. J. Winchester. 2004. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113: 1722-1733.
27. lpr mice. J. Exp. Med. 190: 1813-1824.
28. Panzer, U., O. M. Steinmetz, R. A. Stahl, and G. Wolf. 2006. Kidney diseases and chemokines. Curr. Drug Targets 7: 65-80.
29. lpr mice. J. Am. Soc. Nephrol. 15: 1504-1513.
30. Chang, S. K., B. K. Arendt, J. R. Darce, X. Wu, and D. F. Jelinek. 2006. A role for BLyS in the activation of innate immune cells. Blood 108: 2687-2694.
31. Timoshanko, J. R., A. R. Kitching, Y. Iwakura, S. R. Holdsworth, and P. G. Tipping. 2004. Leukocyte-derived interleukin-1β interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am. J. Pathol. 164: 1967-1977.
32. Jacob, C. O., and H. O. McDevitt. 1988. Tumour necrosis factor-α in murine autoimmune "lupus" nephritis. Nature 331: 356-358.
33. Brennan, D. C., M. A. Yui, R. P. Wuthrich, and V. E. Kelley. 1989. Tumor necrosis factor and IL-1 in New Zealand Black/White mice: enhanced gene expression and acceleration of renal injury. J. Immunol. 143: 3470-3475.
34. 1 mice. J. Exp. Med. 179: 305-310.
35. Ji, J. D., I. Tassiulas, K. H. Park-Min, A. Aydin, I. Mecklenbrauker, A. Tarakhovsky, L. Pricop, J. E. Salmon, and L. B. Ivashkiv. 2003. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. 197: 1573-1583.
36. Tipping, P. G., and J. Timoshanko. 2005. Contributions of intrinsic renal cells to crescentic glomerulonephritis. Nephron Exp. Nephrol. 101: e173-e178.
37. Llorente, L., Y. Richaud-Patin, C. Garcia-Padilla, E. Claret, J. Jakez-Ocampo, M. H. Cardiel, J. Alcocer-Varela, L. Grangeot-Keros, D. Alarcon-Segovia, J. Wijdenes, et al. 2000. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43: 1790-1800.
38. Aringer, M., G. Steiner, W. B. Graninger, E. Hofler, C. W. Steiner, and J. S. Smolen. 2007. Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 56: 274-279.
39. Furuzawa-Carballeda, J., M. I. Vargas-Rojas, and A. R. Cabral. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6: 169-175.
40. Anders, H. J., V. Vielhauer, M. Kretzler, C. D. Cohen, S. Segerer, B. Luckow, L. Weller, H. J. Grone, and D. Schlondorff. 2001. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J. Am. Soc. Nephrol. 12: 919 -931.
41. Hill, G. S., M. Delahousse, D. Nochy, P. Remy, F. Mignon, J. P. Mery, and J. Bariety. 2001. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int. 59: 304-316.
42. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
43. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukocyte Biol. 73: 209-212.